In addition, the relationship among glucocorticoids, BDNF function and negative regulators of the Erk1/2 pathway, such as Sprouty4, represents a promising avenue for understanding the contribution of neurotrophin-mediated TrkB signaling in mood disorders. This evidence concerns the gene MAPK3 and mood disorder.